SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | n/a |
Book Value / Share | n/a |
Price / Book | n/a |
NCAV ($M) | 0.00 |
NCAV / Share | n/a |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | n/a |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | n/a |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | n/a |
Assets | n/a |
Liabilities | n/a |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | n/a |
Operating Income | n/a |
Net Income | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | n/a |
Cash from Investing | n/a |
Cash from Financing | n/a |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
100 | 1,230 | 8.13 | |
2,302 | 8,262 | 27.86 | |
11,226 | 20,906 | 53.70 | |
(click for more detail) |
Similar Companies | |
---|---|
PVCT – Provectus Biopharmaceuticals, Inc. | PXMD – PaxMedica, Inc. |
PXYN – Praxsyn Corporation | QBIO – Q BioMed Inc. |
QRON – Qrons Inc. |
Financial data and stock pages provided by
Fintel.io